CAS 157141-27-0
:Cyanomethylenetributylphosphorane
- Cyanomethylenetri-n-butylphosphorane
- (Tributyl-Lambda~5~-Phosphanylidene)Acetonitrile
Cyanomethylenetributylphosphorane
CAS:Formula:C14H28NPPurity:>97.0%(T)Color and Shape:Yellow to Amber to Dark purple clear liquidMolecular weight:241.36{[Tri(but-1-yl)]phosphoranylidene}acetonitrile
CAS:{[Tri(but-1-yl)]phosphoranylidene}acetonitrileFormula:C14H28NPPurity:98%Color and Shape:Light yellow to brown. Liquid-ClearMolecular weight:241.352582-(Tributylphosphoranylidene)acetonitrile
CAS:Formula:C14H28NPPurity:97%Color and Shape:LiquidMolecular weight:241.3526Ref: IN-DA001P8O
1kgTo inquire500gTo inquire250mg20.00€1g24.00€5g52.00€10g60.00€25g128.00€50g195.00€100g298.00€250g576.00€5kg6,269.00€10kg11,284.00€Cyanomethylenetributylphosphorane
CAS:2-(Tributylphosphoranylidene)acetonitrileFormula:C14H28NPPurity:98%Molecular weight:241.35Cyanomethylenetributylphosphorane
CAS:Formula:C14H28NPPurity:95%Color and Shape:LiquidMolecular weight:241.359Cyanomethylenetributylphosphorane
CAS:Cyanomethylenetributylphosphorane (CMTP) is an agent used for the diagnosis of body formation. It is a chemical compound that can be used to produce images of tissue and organs by detecting apoptosis, or programmed cell death. CMTP binds to the glucose-dependent insulinotropic polypeptide receptor (GIPR), stimulating the release of insulin in the pancreas. CMTP also has therapeutic potential for metabolic disorders, as it has been shown to reduce triglycerides and increase HDL cholesterol levels in human serum. CMTP is synthesized from trifluoroacetic acid, which is then reacted with a cyclic peptide containing an amino acid derivative and 1-methyl-2-pyrrolidinone. This reaction produces a molecule with one free amino group at one end and two free carboxylic acid groups at the other end. The molecule can be reacted with epidermal growth factor (EGF) or insulin to
Formula:C14H28NPPurity:Min. 95%Color and Shape:Yellow To Dark Brown Clear LiquidMolecular weight:241.35 g/mol





